Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 24:17585732251350116.
doi: 10.1177/17585732251350116. Online ahead of print.

A UK-based consensus exercise to determine the most acceptable method of suprascapular nerve block injection for people consulting with rotator cuff disorders

Affiliations

A UK-based consensus exercise to determine the most acceptable method of suprascapular nerve block injection for people consulting with rotator cuff disorders

Neil Smith et al. Shoulder Elbow. .

Abstract

Introduction: Suprascapular nerve block (SSNB) injections are used to treat shoulder pain in clinical practice. Its effectiveness compared to other shoulder pain relieving injections requires evaluation in high quality clinical trials. A range of different methods are used for SSNB injections. This study aimed to gain expert consensus on the most acceptable method of delivering SSNB injection in a future comparative clinical trial.

Methods: Between October 2023 and May 2024, we conducted a three stage, online, modified Delphi survey with NHS clinicians who currently perform SSNB injections in the United Kingdom.

Results: Thirty-eight NHS registered healthcare professionals completed Stage 1, 34 completed Stage 2 and 25 completed Stage 3. Anatomical land-marked and ultrasound guided SSNB injection methods reached consensus as acceptable to use in a multi-centre clinical trial. Targeting the supraspinatus fossa (SSF) or the suprascapular notch (SSN) reached consensus as acceptable. Finally, Kenalog (40 mg) or Depo-medrone (40 mg) combined with either Bupivacaine 0.25% (5-10 ml), Bupivacaine 0.5% (5 ml to10 ml), Lidocaine 1% (5-10 ml) all reached consensus as acceptable injectates.

Conclusions: This consensus study has provided valuable information from expert NHS clinicians to help determine the method of SSNB injection delivery in the conduct of a future clinical trial.

Keywords: Delphi; consensus; suprascapular nerve block.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Study Flow.

Similar articles

References

    1. Walker-Bone K, van der Windt DA. Shoulder pain—where are we now? Curr Treatm Opt Rheumatol 2021; 7: 285–306.
    1. van der Windt DA, Burke DL, Babatunde O, et al. Predictors of the effects of treatment for shoulder pain: protocol of an individual participant data meta-analysis. Diagn Progn Res 2019; 3: 15. - PMC - PubMed
    1. Chaudhury S, Musa A, Abdulmawjod AA, et al. Rotator cuff tears. Orthop Trauma 2022; 36: 144–151.
    1. Minns Lowe CJ, Moser J, Barker K. Living with a symptomatic rotator cuff tear ‘bad days, bad nights’: a qualitative study. BMC Musculoskelet Disord 2014; 15: 228. - PMC - PubMed
    1. Howard A, Woods A, Rombach I, et al. SPiRIT study protocol (shoulder pain: randomised trial of injectable treatments): a randomised feasibility and pilot study of autologous protein solution (APS) vs corticosteroids for treating subacromial shoulder pain. Pilot Feasibility Stud 2024; 10: 9. - PMC - PubMed

LinkOut - more resources